In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 10288-72-9, name is 6-Hydroxy-1,4-benzodioxane, introducing its new discovery. Product Details of 10288-72-9
Acylbenzoxazines for enhancing synaptic response
Compounds based on the benzoxazine ring system that are remarkably more potent than corresponding benzoyl piperidines for enhancing synaptic responses mediated by AMPA receptors are disclosed, as are methods for the preparation thereof, and methods for their use for treatment of subjects suffering from impaired nervous or intellectual functioning due to deficiencies in the number of excitatory synapses or in the number of AMPA receptors. The invention compounds can also be used for the treatment of non-impaired subjects for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptors and for improving memory encoding.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 10288-72-9, and how the biochemistry of the body works.Product Details of 10288-72-9
Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem